Checkpoint inhibition for early-stage hormone receptor-positive breast cancer
{{output}}
Introduction: Most patients with breast cancer have early-stage hormone receptor (HR)-positive, human epidermal growth factor receptor-2 (HER2)-negative disease. Even though the prognosis for most of these patients is good, there... ...
